# Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

> **NCT02771574** · PHASE2 · COMPLETED · sponsor: **Tracey McLaughlin** · enrollment: 19 (actual)

## Conditions studied

- Post Bariatric Hypoglycemia

## Interventions

- **DRUG:** Lyo avexitide
- **DRUG:** Liq avexitide

## Key facts

- **NCT ID:** NCT02771574
- **Lead sponsor:** Tracey McLaughlin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02771574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02771574, "Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02771574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*